Maryland House Bill 162 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 13 2021 - 25% progression, died in committee
Action: 2020-12-23 - Hearing 1/27 at 1:30 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Altering a certain requirement that the Prescription Drug Affordability Board, in conjunction with a certain council, draft a certain plan for setting upper payment limits for prescription drug products; altering the date by which the Board is required to submit the plan to a certain committee of the General Assembly; requiring, rather than authorizing, the Board to set upper payment limits for certain prescription drug products and altering the date by which the limits are to be set to on or after February 1, 2022; etc.

Prescription Drug Affordability Board – Upper Payment Limits and Reports

Del. Julian Ivey [D]

Date	Chamber	Action
2020-12-23	House	Hearing 1/27 at 1:30 p.m.
2021-01-13	House	First Reading Health and Government Operations
2020-10-25	House	Pre-filed

Chapter	Article	Section	Citation Type	Statute Text
Chapter of the Acts	2019		(n/a)	See Bill Text
Chapter of the Acts	2020		(n/a)	See Bill Text
Health - General	21	2C-01	(n/a)	See Bill Text
Health - General	21	2C-07	(n/a)	See Bill Text
Health - General	21	2C-08	(n/a)	See Bill Text
Health - General	21	2C-13	(n/a)	See Bill Text
Health - General	21	2C-14	(n/a)	See Bill Text
Health - General	21	2C-16	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0162?ys=2021RS
Text	https://mgaleg.maryland.gov/2021RS/bills/hb/hb0162f.pdf